Aerophagia and Gastroesophageal Reflux Disease in Patients using Continuous Positive Airway Pressure: A Preliminary Observation
2008; American Academy of Sleep Medicine; Volume: 04; Issue: 05 Linguagem: Inglês
10.5664/jcsm.27278
ISSN1550-9397
AutoresNathaniel F. Watson, Sue K. Mystkowski,
Tópico(s)Eosinophilic Esophagitis
ResumoFree AccessCPAPAerophagia and Gastroesophageal Reflux Disease in Patients using Continuous Positive Airway Pressure: A Preliminary Observation Nathaniel F. Watson, M.D., Sue K. Mystkowski, M.D. Nathaniel F. Watson, M.D. Address correspondence to: Nathaniel F. Watson, University of Washington Sleep Disorders Center at Harborview, Box 359803, 325 Ninth Avenue, Seattle, WA 98104-2499(206) 744-4337(206) 744-5657 E-mail Address: [email protected] Department of Neurology, University of Washington, Seattle, WA , Sue K. Mystkowski, M.D. Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA Published Online:October 15, 2008https://doi.org/10.5664/jcsm.27278Cited by:18SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTStudy Objectives:Aerophagia is a complication of continuous positive airway pressure (CPAP) therapy for sleep disordered breathing (SDB), whereupon air is forced into the stomach and bowel. Associated discomfort can result in CPAP discontinuation. We hypothesize that aerophagia is associated with gastroesophageal reflux disease (GERD) via mechanisms involving GERD related lower esophageal sphincter (LES) compromise.Methods:Twenty-two subjects with aerophagia and 22 controls, matched for age, gender, and body mass index, who were being treated with CPAP for SDB were compared in regard to clinical aspects of GERD, GERD associated habits, SDB severity as measured by polysomnography, and mean CPAP pressure.Results:More subjects with aerophagia had symptoms of GERD (77.3% vs. 36.4%; p < 0.01) and were on GERD related medications (45.5% vs. 18.2%, p < 0.05) than controls. Regarding polysomnography, mean oxygen saturation percentages were lower in the aerophagia group than controls (95.0% vs. 96.5%, p < 0.05). No other differences were observed, including mean CPAP pressures. No one in the aerophagia group (vs. 27.3% of the control group) was a current tobacco user (p < 0.01). There was no difference in caffeine or alcohol use between the 2 groups.Conclusions:These results imply aerophagia is associated with GERD symptoms and GERD related medication use. This finding suggests a relationship between GERD related LES pathophysiology and the development of aerophagia in patients with SDB treated with CPAP.Citation:Watson NF; Mystkowski SK. Aerophagia and gastroesophageal reflux disease in patients using continuous positive airway pressure: a preliminary observation. J Clin Sleep Med 2008;4(5):434–438.INTRODUCTIONContinuous positive airway pressure (CPAP), the preferred treatment for sleep disordered breathing (SDB), involves delivery of pressurized air into the upper airway via nasal or oronasal masks. CPAP provides a pneumatic splint, thereby resolving SDB by preventing pharyngeal collapse during sleep. Aerophagia is a complication of CPAP, in which air is inadvertently injected into the stomach and bowel resulting in painful abdominal bloating, belching, and flatulence. CPAP compliance frequently suffers, with patients often discontinuing treatment altogether due to these symptoms. The exact prevalence of CPAP related aerophagia in SDB is unknown, although one study found a prevalence of 13% in patients with chronic respiratory failure treated with noninvasive positive pressure ventilation.1Gastroesophageal reflux disease (GERD), defined by at least weekly heartburn and/or acid regurgitation, is a common medical disorder affecting 10% to 20% of the population in the Western world.2 Nocturnal symptoms are common, with 2 nationwide telephone surveys reporting that 74% to 79% of adults with weekly GERD experience comorbid nighttime symptoms.3 Reflux events typically occur during transient relaxations of the lower esophageal sphincter (LES), the primary antireflux barrier.4 Patients with GERD develop pathophysiological changes at the gastroesophageal junction, which compromise the LES, predisposing to reflux during these intermittent episodes of sphincter relaxation.4,5 We hypothesize that GERD associated gastroesophageal pathology creates an environment susceptible to aerophagia in patients on CPAP for SDB. Therefore, the goal of this research is to establish an association between aerophagia and GERD.METHODSAscertainment of Obstructive Sleep Apnea and AerophagiaThis case-control study involved patients treated at the University of Washington Sleep Disorders Center at Harborview between 2005 and 2006. Sleep disordered breathing was defined as an apnea-hypopnea index (AHI) > 10 on polysomnography (PSG) along with corresponding symptomology (e.g., snoring, excessive daytime sleepiness, morning headaches, witnessed apneas). Apneas were defined by ≥ 90% reduction in the pressure flow signal with corresponding respiratory effort; hypopneas were defined as 50% to 90% reduction in signal with corresponding respiratory effort. All study subjects were diagnosed with SDB and treated with CPAP.All patients with SDB treated with CPAP at our sleep center were eligible for inclusion in the study group. All patients were queried regarding CPAP complications at follow-up visits, which include issues such as mask and oral leak of air, nasal congestion, mask discomfort, feelings of claustrophobia, and aerophagia. Any history of painful abdominal bloating, eructation, or flatulence related to CPAP use was considered positive for aerophagia. Patients with a prior history of esophageal or gastric surgery were excluded as the effect of these procedures on CPAP related aerophagia is unknown. Age-, gender-, and body mass index (BMI)- matched controls were randomly selected from a clinical database representing patients seen at our sleep center between 2002 and 2006. During the initial clinic visit all subjects were assessed with a standardized questionnaire for clinical evidence of GERD (symptoms, history of physician diagnosis); current GERD related medication use (proton pump inhibitors, H2 blockers, and antacids); and GERD related habits (current tobacco, caffeine, and alcohol use). GERD symptoms included endorsement of heartburn on review of systems. Physician diagnosis of GERD was established from the past medical history, and GERD related medications were extracted from the patient's medication list at the initial clinic visit and again prior to the diagnostic polysomnogram. Habits related to GERD were ascertained from the social history. The combined endpoint of any GERD factor included the presence of any combination of the aforementioned GERD related items (symptoms, physician diagnosis, and medication use). This study was reviewed and approved by the UW Human Subjects Committee.PolysomnographyEEG electrodes were positioned at 2 frontal (F7, F8), 2 central (C3, C4), and 2 occipital (O1, O2) locations (International 10–20 system of measurement) and were referenced to the contralateral mastoids. Chin electromyogram and right and left electro-oculogram electrodes were also applied. Airflow was measured using a nasal pressure cannula placed in the nose (Pro-Tech Services, Inc. Mukilteo, WA). Chest and abdominal respiratory effort were measured by piezo respiratory effort bands placed around the chest and abdomen (Pro-Tech Services, Inc. Mukilteo, WA). Oxygen saturation was measured from the left or right index finger via pulse oximetry (Nellcor, Pleasanton, CA). Snoring was assessed by a small microphone sensor (Pro-Tech Services, Inc. Mukilteo, WA) placed on the throat just lateral to the trachea. Electromyogram electrodes were placed on the anterior tibialis muscle of each leg to monitor leg movements. The electrocardiogram was measured via 2 leads placed according to the modified lead II configuration. Measured PSG characteristics included AHI, desaturation index, oxygen saturation nadir, oxygen saturation mean, arousal index, total sleep time, sleep efficiency, sleep latency, and prescribed CPAP pressure. All PSGs were scored in accordance with Rechtschaffen and Kales criteria.6 All PSGs were single-night diagnostic studies. All subjects underwent diagnostic polysomnography and were treated with CPAP within 30 days of their initial clinic visit.Statistical AnalysisThe nonparametric chi-square test was utilized for all statistical analyses involving binary exposure and outcome variables except for tobacco (Fischer exact test) due to sample size. Continuous outcome variables obtained from PSG were assessed with Student's t-test with unequal variances. Stata 9.0 statistical software package was used (StataCorp LP, College Station, TX).RESULTSAs expected, the aerophagia and control groups were similar in age (49.3 vs. 48.9 y), gender (both groups 50% female), and BMI (31.1 vs. 31.0 kg/m2). The group with aerophagia demonstrated more GERD symptoms (77.3% vs. 36.4%, p < 0.01) and were taking more GERD-related medications (45.5% vs. 18.2%, p < 0.05) than the control group. In addition, the combined GERD endpoint of any symptoms, medication use, or physician diagnosis of GERD was more common in the aerophagia group than the controls (77.3% vs. 40.9%, p < 0.05). Interestingly, 27.3% of the control group endorsed current smoking; no one in the aerophagia group reported smoking (p < 0.01). Current caffeine and alcohol use was similar regardless of aerophagia status. Regarding PSG, the aerophagia group had a lower mean oxygen saturation level when compared to the control group (95.0% vs. 96.5%; p < 0.05). No other significant differences were observed. These results are summarized in Table 1.Table 1 Clinical and Polysomnographic Variables in Patients with Sleep Disordered Breathing on CPAP with and without AerophagiaAerophagia (n = 22)Controls (n = 22)p-valueClinical Variables (%) Symptoms of GERD77.336.4<0.01 Medications for GERD45.518.2<0.05 Physician diagnosis of GERD50.027.30.12 Any GERD*77.340.9<0.05 Caffeine**72.768.20.74 Tobacco**0.027.3<0.01 Alcohol**50.068.20.22Polysomnographic Variables: Mean (95% CI) AHI (events/hr)38.3 (31.0–45.6)43.9 (29.5–58.3)0.48 Desaturation index†10.9 (6.2–15.6)11.0 (5.5–16.5)0.98 Oxygen nadir (%)87.1 (84.4–89.9)88.7 (85.9–91.5)0.40 Oxygen mean (%)95.0 (93.9–96.1)96.5 (95.8–97.2) 3% from baseline per hour. One patient in the control group was missing CPAP data and one patient from the aerophagia group was missing desaturation index data. Chi-square test for all analyses except for tobacco (Fisher exact test).GERD = gastroesophageal reflux disease, AHI = apnea-hypopnea index, TST = total sleep time, CPAP = continuous positive airway pressure.DISCUSSIONThis pilot study revealed a positive association between aerophagia and GERD symptoms and GERD-related medication use in patients using CPAP for SDB. The endpoint of the presence of any one of GERD symptoms, medication use, or physician diagnosis was more common in the aerophagia group. There are a number of potential physiological explanations for this association. Gastroesophageal reflux in normal individuals is closely related to transient LES relaxation episodes that occur during wakefulness and brief arousals from sleep.7,8 Patients with GERD are at increased risk of reflux events during these transient episodes of relaxation.4 These factors could provide an esophageal environment conducive to the development of aerophagia. Also, gastric distention is a potent stimulator of transient LES relaxation.8 Therefore, once initiated, aerophagia-associated increases in gastric pressure could create a positive feedback loop, leading to further air swallowing by the patient, with worsening aerophagia and increasing reflux.Interestingly, we found that controls were more likely to smoke than the aerophagia group. Nicotine transiently decreases LES tone, thereby contributing to GERD development.9,10 However, the effects of smoking on LES tone are self-limited, and would not extend into the sleep period.9,10 Smoking also diminishes the esophago-upper esophageal sphincter contractile reflex (EUCR) and secondary peristalsis (2P), with triggering volumes 2.6 times as high in smokers as nonsmokers.11 The EUCR/2P is a reflex contraction of the upper esophageal sphincter followed by non-deglutitive esophageal peristalsis. It has been shown that esophageal distention with air triggers a peristaltic response that traverses the entire esophagus.12 Animal models have demonstrated triggering of the EUCR/2P reflex by esophageal distension with air applied in a slow, continuous manner.13 In humans, stimulation of the EUCR/2P in NREM sleep can take ≥ 3.5 min from the application of the stimulus to triggering of the reflex, with multiple peristaltic events occurring per EUCR activation.14 Therefore, the inhibiting effect of smoking on the EUCR/2P might explain the reduced prevalence of aerophagia in smokers. Further speculation suggests that activation of the EUCR/2P reflex by CPAP could contribute to the development of aerophagia in patients with SDB. Additional research investigating the potential role of the EUCR/2P in aerophagia is necessary before these conclusions can be definitively drawn. Figure 1 is a theoretical model summarizing these physiological relationships and their potential contribution to the development of aerophagia.Figure 1 Theoretical model of the relationship between gastroesophageal reflux disease (GERD) and aerophagia following continuous positive airway pressure (CPAP) therapy for sleep disordered breathing (SDB). LES = lower esophageal sphincter; EUCR/2P = esophago-upper esophageal sphincter contractile reflex and secondary peristalsis. Solid lines indicate relationships predisposing to aerophagia. Dotted lines indicate relationships reducing aerophagia.Download FigureGERD is common in patients with SDB, occurring in 54% to 76% of patients.15,16 Interestingly, CPAP reduces GERD symptoms in SDB patients predominantly through increased intraesophageal pressure, with higher CPAP pressures causing greater symptom relief.17–19 Therefore it appears the same air pressure that relieves GERD symptoms by forcing refluxate back into the stomach also has the potential to cause aerophagia in susceptible individuals. CPAP also reflexively increases LES tone. As previously discussed, exposure of the gastroesophageal junction to refluxate compromises the LES over time.4 Therefore, CPAP and chronic reflux have opposite effects on LES tone. Overall, the balance of this relationship appears to favor compromised LES tone, since CPAP improves, but does not completely resolve, GERD symptoms,19 leading to the association we observe between GERD and aerophagia in the current study.We found a slight reduction in mean SpO2 in the aerophagia group, suggesting more severe SDB in these subjects. However, the lack of differences in other SDB related PSG variables between the 2 groups, particularly CPAP pressures, argues against this notion. Regarding other habits, our finding of no relationship between alcohol and caffeine use and aerophagia are consistent with the literature showing no clear association between specific types of food and GERD.4We observed a trend toward increased physician-diagnosed GERD in subjects with aerophagia, supporting our findings of an association between aerophagia, GERD symptoms, and medication use. The lack of a significant association here likely reflects frequent self-medication with over-the-counter remedies by patients with GERD symptoms.20 This is not unusual considering that proton pump inhibitors and H2 blockers are both highly effective and available without a prescription. Therefore a formal diagnosis by a physician may be considered unnecessary and not sought by the patient.Current treatments for aerophagia, such as avoiding bedtime meals, propping the head of the bed, and reducing mean airway pressure with autotitrating PAP, are marginally effective. The apparent role of the LES in aerophagia presents the possibility of novel treatments. The antimuscarinic medication atropine reduces secondary peristalsis following the introduction of air into the esophagus.12 Perhaps other antimuscarinics, such as scopolamine, would prevent aerophagia. Similarly, certain SDB cases may benefit from laparoscopic or open gastric fundoplication around the lower esophagus to mitigate aerophagia and allow ongoing CPAP treatment. This option has potential importance in severely affected patients at high cardiovascular risk. Clearly, further research is needed into the prevention and treatment of aerophagia before any of these interventions can be recommended.What can aerophagia teach us about GERD? Could this be a clinical sign of more severe GERD? Should these patients be evaluated for a hiatal hernia? Are patients with aerophagia without GERD symptoms prone to future GERD development? These issues deserve further investigation. In the meantime, clinicians may wish to refer aerophagia patients to gastroenterologists for detailed esophageal evaluations.Our study has limitations, as we lack objective measures of GERD and aerophagia. Also, we did not gather CPAP compliance data or assess all patients at risk. As a result, we cannot comment on the prevalence of aerophagia or its effect on CPAP usage. Also, we did not ascertain time of initial GERD diagnosis or initial exposure to anti-GERD medications in relation to the development of aerophagia. Nevertheless, we feel that ongoing treatment with anti-GERD medications and concurrent symptomology are strong indicators that these patients were exhibiting GERD pathophysiology at the time they developed aerophagia. Overall, the findings of this pilot study suggest that future studies with objective GERD and aerophagia measures are warranted.In conclusion, we demonstrate an association between GERD symptoms and medication use and CPAP-related aerophagia. We propose a mechanism involving transient LES relaxation in GERD-related LES compromise. Once initiated, gastric bloating may serve to further increase transient LES relaxation, creating a feedback loop worsening the aerophagia. Triggering of the EUCR/2P by CPAP pressure in the proximal esophagus may also contribute to aerophagia development, as supported by the finding that smoking, which inhibits the EUCR/2P, was protective against aerophagia in our sample. Future studies should focus on objective measures of GERD, aerophagia, and CPAP compliance, and the impact of GERD treatment, both medical and surgical, on aerophagia.DISCLOSURE STATEMENTThis was not an industry supported study. The authors have indicated no financial conflicts of interest.REFERENCES1 Criner GJ, Brennan K, Travaline JM, et al.Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failureChest199911666775, 10492269 CrossrefGoogle Scholar2 Dent J, El-Serag HB, Wallander MA, et al.Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut20055471017, 15831922 CrossrefGoogle Scholar3 Shaker R, Castell DO, Schoenfeld PS, et al.Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological AssociationAm J Gastroenterol200398148793, 12873567 CrossrefGoogle Scholar4 Fox M, Forgacs IGastro-oesophageal reflux diseaseBMJ20063328893, 16410582 CrossrefGoogle Scholar5 Rex DK, Cummings OW, Shaw M, et al.Screening for Barrett's esophagus in colonoscopy patients with and without heartburnGastroenterology200312516701677, 14724819 CrossrefGoogle Scholar6 Rechtschaffen A, Kales AA manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects1968Los AngelesBrain Information Service/Brain Research Institute, UCLA Google Scholar7 Dodds WJ, Dent J, Hogan WJ, et al.Mechanisms of gastroesophageal reflux in patients with reflux esophagitisN Engl J Med1982307154752, 7144836 CrossrefGoogle Scholar8 Mittal RK, Holloway RH, Penagini R, et al.Transient lower esophageal sphincter relaxationGastroenterology199510960110, 7615211 CrossrefGoogle Scholar9 Stanciu C, Bennett JRSmoking and gastro-oesophageal refluxBr Med J197237935, 5076250 CrossrefGoogle Scholar10 Dennish GW, Castell DOInhibitory effect of smoking on the lower esophageal sphincterN Engl J Med197128411367, 5553487 CrossrefGoogle Scholar11 Dua K, Bardan E, Ren J, et al.Effect of chronic and acute cigarette smoking on the pharyngo-upper oesophageal sphincter contractile reflex and reflexive pharyngeal swallowGut19984353741, 9824582 CrossrefGoogle Scholar12 Schoeman MN, Holloway RHStimulation and characteristics of secondary oesophageal peristalsis in normal subjectsGut1994351528, 8307463 CrossrefGoogle Scholar13 Lang IM, Medda BK, Shaker RMechanisms of reflexes induced by esophageal distensionAm J Physiol Gastrointest Liver Physiol2001281G124663, 11668034 CrossrefGoogle Scholar14 Bajaj JS, Bajaj S, Dua KS, et al.Influence of sleep stages on esophago-upper esophageal sphincter contractile reflex and secondary esophageal peristalsisGastroenterology20061301725, 16401464 CrossrefGoogle Scholar15 Graf KI, Karaus M, Heinemann S, et al.Gastroesophageal reflux in patients with sleep apnea syndromeZ Gastroenterol19953368993, 8585249 Google Scholar16 Teramoto S, Ohga E, Matsui H, et al.Obstructive sleep apnea syndrome may be a significant cause of gastroesophageal reflux disease in older peopleJ Am Geriatr Soc19994712734, 10522968 CrossrefGoogle Scholar17 Dent J, Dodds WJ, Friedman RH, et al.Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjectsJ Clin Invest19806525667, 7356677 CrossrefGoogle Scholar18 Kerr P, Shoenut JP, Steens RD, et al.Nasal continuous positive airway pressure. A new treatment for nocturnal gastroesophageal reflux?J Clin Gastroenterol19931727680, 8308210 CrossrefGoogle Scholar19 Green BT, Broughton WA, O'Connor JBMarked improvement in nocturnal gastroesophageal reflux in a large cohort of patients with obstructive sleep apnea treated with continuous positive airway pressureArch Intern Med2003163415, 12523915 CrossrefGoogle Scholar20 Pettit MTreatment of gastroesophageal reflux diseasePharm World Sci2005274325, 16341949 CrossrefGoogle Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Perioperative Continuous Positive Airway Pressure Therapy: A Review With the Emphasis on Randomized Controlled Trials and Obstructive Sleep ApneaJonsson Fagerlund M and Franklin K Anesthesia & Analgesia, 10.1213/ANE.0000000000005480, Vol. 132, No. 5, (1306-1313), Online publication date: 1-May-2021. Effect of continuous positive airway pressure on gastroesophageal reflux in patients with obstructive sleep apnea: a meta-analysisLi C, Wu Z, Pan X and Yuan K Sleep and Breathing, 10.1007/s11325-020-02224-9 The effect of postoperative CPAP use on anastomotic and staple line leakage after bariatric surgeryReijers S, Nijland L, Bosschieter P, de Raaff C, Ravesloot M, van Veen R, de Castro S and de Vries N Sleep and Breathing, 10.1007/s11325-020-02199-7 Treatment of Obstructive Sleep ApneaLettieri C, Williams S, Collen J and Wickwire E Sleep Medicine Clinics, 10.1016/j.jsmc.2020.02.009, Vol. 15, No. 2, (227-240), Online publication date: 1-Jun-2020. Novel Use of Impedance Technology Shows That Esophageal Air Events Can Be Temporally Associated With Gastroesophageal Reflux Disease-like SymptomsWoodley F, Ciciora S, Vaz K, Williams K, Di Lorenzo C and Jadcherla S Journal of Pediatric Gastroenterology & Nutrition, 10.1097/MPG.0000000000002514, Vol. 70, No. 1, (e7-e11), Online publication date: 1-Jan-2020. Obstructive Sleep Apnea in Pregnant WomenDominguez J, Krystal A and Habib A Anesthesia & Analgesia, 10.1213/ANE.0000000000003335, Vol. 127, No. 5, (1167-1177), Online publication date: 1-Nov-2018. Treatment of Obstructive Sleep ApneaLettieri C, Williams S, Collen J and Wickwire E Sleep Medicine Clinics, 10.1016/j.jsmc.2017.07.005, Vol. 12, No. 4, (551-564), Online publication date: 1-Dec-2017. A Randomized Crossover Trial Comparing Autotitrating and Continuous Positive Airway Pressure in Subjects With Symptoms of Aerophagia: Effects on Compliance and Subjective SymptomsShirlaw T, Hanssen K, Duce B and Hukins C Journal of Clinical Sleep Medicine, Vol. 13, No. 07, (881-888), Online publication date: 15-Jul-2017. Evaluation of oxygen administration with a high-flow nasal cannula to clinically normal dogsDaly J, Guenther C, Haggerty J and Keir I American Journal of Veterinary Research, 10.2460/ajvr.78.5.624, Vol. 78, No. 5, (624-630), Online publication date: 1-May-2017. Does CPAP treatment lead to gastroesophageal reflux in patients with moderate and severe OSA?Ozcelik H, Kayar Y, Danalioglu A, Arabaci E, Uysal O, Yakar F and Kart L European Archives of Oto-Rhino-Laryngology, 10.1007/s00405-016-4116-0, Vol. 274, No. 3, (1223-1229), Online publication date: 1-Mar-2017. Sultan M and Lewis J Miscellaneous Upper Gastrointestinal Symptoms Practical Gastroenterology and Hepatology Board Review Toolkit, 10.1002/9781119127437.ch10, (56-69) Managing a patient with excessive belchingDisney B and Trudgill N Frontline Gastroenterology, 10.1136/flgastro-2013-100355, Vol. 5, No. 2, (79-83), Online publication date: 1-Apr-2014. Symptoms of Aerophagia Are Common in Patients on Continuous Positive Airway Pressure Therapy and Are Related to the Presence of Nighttime Gastroesophageal RefluxShepherd K, Hillman D and Eastwood P Journal of Clinical Sleep Medicine, Vol. 09, No. 01, (13-17), Online publication date: 15-Jan-2013. Protocolo diagnóstico de la aerofagiaLópez Higueras A Medicine - Programa de Formación Médica Continuada Acreditado, 10.1016/S0304-5412(12)70259-7, Vol. 11, No. 1, (52-56), Online publication date: 1-Jan-2012. Cao M, Guilleminault C and Kushida C Clinical Features and Evaluation of Obstructive Sleep Apnea and Upper Airway Resistance Syndrome Principles and Practice of Sleep Medicine, 10.1016/B978-1-4160-6645-3.00105-5, (1206-1218), . Gastrointestinal physiology and digestive disorders in sleepKanaly T, Shaheen N and Vaughn B Current Opinion in Pulmonary Medicine, 10.1097/MCP.0b013e3283318539, , (1), Online publication date: 1-Sep-2009. WORN TEETH: Author's responseSpear F The Journal of the American Dental Association, 10.14219/jada.archive.2009.0178, Vol. 140, No. 4, (401), Online publication date: 1-Apr-2009. CPAP and Things That Go "Burp" in the NightOrr W Journal of Clinical Sleep Medicine, Vol. 04, No. 05, (439-440), Online publication date: 15-Oct-2008. Volume 04 • Issue 05 • October 15, 2008ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Submitted for publicationFebruary 1, 2008Accepted for publicationMay 1, 2008Published onlineOctober 15, 2008 Information© 2008 American Academy of Sleep MedicineKeywordsgastroesophageal reflux diseasecomplicationsaerophagiaContinuous positive airway pressureACKNOWLEDGMENTSThe authors would like to thank Rebecca Larson, Simon Zirians, and Monte Carlow for their assistance in assembling the data for this study.This work was performed at the University of Washington and Harborview Medical Center.PDF download
Referência(s)